
Please try another search
Veritas In Silico Inc. engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. It has strategic partnership with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. The company was incorporated in 2016 and is based in Shinagawa, Japan.
Name | Age | Since | Title |
---|---|---|---|
Sadao Suzuki | 73 | 2019 | Full-Time Audit & Supervisory Board Member |
Minako Wakabayashi | 53 | 2022 | Outside Audit & Supervisory Board Member |
Minoru Hirooka | 54 | 2017 | Outside Audit & Supervisory Board Member |
Kinichiro Kominami | 58 | 2019 | Independent Outside Director |
Isao Koda | 68 | 2024 | Executive Officer & Director |
Hiroaki Hagiwara | 56 | 2024 | Director & Executive Officer of Administration Division |
Shingo Nakamura | 53 | 2016 | Founder, President, CEO & Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review